(Q33340188)

25 July 2017

title

Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix (English)

1 reference

25 July 2017

1 reference

1 reference

C F Verschraegen

1

1 reference

25 July 2017

J J Kavanagh

2

1 reference

25 July 2017

E Loyer

3

1 reference

25 July 2017

D Bodurka-Bevers

4

1 reference

25 July 2017

A P Kudelka

5

1 reference

25 July 2017

W Hu

6

1 reference

25 July 2017

M Vincent

7

1 reference

25 July 2017

T Nelson

8

1 reference

25 July 2017

C Levenback

9

1 reference

25 July 2017

Community Clinical Oncology Program

10

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

25 July 2017

1 reference

25 July 2017

volume

92

1 reference

25 July 2017

issue

9

1 reference

25 July 2017

page(s)

2327-2333

1 reference

Epidemiology and biology of cervical cancer

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Current developments in the treatment of newly diagnosed cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Chemotherapy of advanced and recurrent cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Cancer of the Uterine Cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Interactions of doxorubicin and cis-platin in squamous carcinoma cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Clinical studies of liposome-encapsulated doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix--a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2327%3A%3AAID-CNCR1579%3E3.0.CO%3B2-6

10.1002/1097-0142(20011101)92:9<2327::AID-CNCR1579>3.0.CO;2-6

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference